diff options
| author | David A. Madore <david+git@madore.org> | 2020-05-23 02:29:20 +0200 |
|---|---|---|
| committer | David A. Madore <david+git@madore.org> | 2020-05-23 02:29:20 +0200 |
| commit | c548f73f3c3f2b82e32d829c29ab5b509adce269 (patch) | |
| tree | b54c480ff455bd091e5d4a011c5a44794d975426 | |
| parent | dbbeffe9af319170a89353a7aef3fbd1f9a6efaa (diff) | |
| download | covid19-c548f73f3c3f2b82e32d829c29ab5b509adce269.tar.gz covid19-c548f73f3c3f2b82e32d829c29ab5b509adce269.tar.bz2 covid19-c548f73f3c3f2b82e32d829c29ab5b509adce269.zip | |
Link to study on (hydroxy)chloroquine.
| -rw-r--r-- | covid19-links.md | 10 |
1 files changed, 10 insertions, 0 deletions
diff --git a/covid19-links.md b/covid19-links.md index 3917232..3016f84 100644 --- a/covid19-links.md +++ b/covid19-links.md @@ -87,6 +87,16 @@ ## Topical or time-specific links: ## +* [Hydroxychloroquine or chloroquine with or without a macrolide for + treatment of COVID-19: a multinational registry + analysis](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2820%2931180-6) + (2020-05-22, *The Lancet*). Key finding: were unable to confirm a + benefit of hydroxychloroquine or chloroquine, when used alone or + with a macrolide, on in-hospital outcomes for COVID-19. Each of + these drug regimens was associated with decreased in-hospital + survival and an increased frequency of ventricular arrhythmias when + used for treatment of COVID-19. + * [Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold](https://www.medrxiv.org/content/10.1101/2020.04.27.20081893v2) |